Medline Inc. (MDLN): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.94B
As of 2025-12-31
$2.33B
As of 2026-06-27
2024-12-31: $199.00M2025-12-31: $1.94B$1.94B
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.94B+874.4%2026-02-25, Balance as of period end
2024-12-31$199.00Mn/a2026-02-25, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Medline Inc. (MDLN)2025-12-31$1.94B+874.4%
Stryker Corp (SYK)2025-12-31$4.01B+9.8%
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
Boston Scientific Corp (BSX)2025-12-31$1.97B+374.6%
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
Solventum Corp (SOLV)2025-12-31$878.00M+15.2%
ResMed Inc (RMD)2026-06-30$1.47B+21.5%
Dexcom Inc (DXCM)2025-12-31$917.70M+51.4%
MiniMed Group, Inc. (MMED)2026-04-24$298.00Mn/m

Compare MDLN, SYK, BDX, BSX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗